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Conducting clinical trials of Chinese medicines (CM) in hospitals presents challenges for researchers. The success of
hospital-based CM clinical trials may be influenced by the protocol design, including the maintenance of CM theory
in compliance with scientific rigour and hospital guidelines and justified treatment approaches with results that can
translate into clinical practice. Other influences include personnel and resources such as a dedicated team open to
CM with an established research culture and the ability to maximise participant recruitment. This article identifies
the key challenges and limitations of conducting CM clinical trials in Australian hospitals.Commentary
Chinese medicine (CM) treatments, including acupunc-
ture, herbal medicine, remedial manual therapy, and ex-
ercise therapy (Tai Chi) are growing in popularity [1-3].
At the same time the healthcare community have begun
to acknowledge the preferences of patients to receive
treatment with CM in the United Kingdom, United
States and Australia [4-7]. In Australia, CM practitioners
must be registered nationally by the Chinese Medicine
Board of Australia through the Australian Health
Practitioners Regulation Agency in order to practice
acupuncture and prescribe Chinese herbal medicine [8].
The practice and paradigmatic philosophies of CM dif-
fer from those of Western medicine (WM). Traditional
CM diagnostic methods consider factors such as the en-
vironment, seasons, emotions, diet, and lifestyle. In
addition WM diagnostic approaches are also used by
CM practitioners to provide a comprehensive diagnosis
and individualised treatment plan. In contrast, WM fo-
cuses on pathological processes and uses diagnostic
instruments or tests or both to classify illness, and places
less of an emphasis on a person’s interaction with the
environment. These differences may create gaps in com-
munication between the disciplines; however, recently
cooperation has grown [9].
Evidence-based medicine (EBM) including randomized
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reproduction in any medium, provided the orbetween CM and WM. Increasing numbers of RCTs are
being undertaken to determine the efficacy and safety of
CM interventions [10]. CM researchers have been stri-
ving to achieve high standards of scientific rigor through
RCTs. However, this has presented challenges in har-
monizing CM theory and the RCT design required to
enable effective translation [11].
Given the relatively short history of RCTs in CM out-
side China, a substantial proportion of CM studies were
usually conducted in universities or community clinics.
In Australia, hospitals are increasingly involved in clin-
ical studies since the introduction of national strategies
and processes to encourage greater engagement and par-
ticipation of hospitals in research [12]. A search of the
Australian and New Zealand Clinical Trials Registry
(ANZCTR) on 23 August 2012 identified 144 alternative
and complementary medicine RCTs with ethical ap-
proval being conducted in Australia. Of these, 71 were
CM studies, and 16 were identified as being conducted
in hospitals. The availability of participants (e.g., acute,
sub-acute and outpatients), easy access to hospital
resources (e.g., functional magnetic resonance imaging,
fMRI) and medical expertise are major factors which
make hospitals suitable environments for undertaking
CM clinical trials.
As a typical example, this paper will highlight some of
the challenges of undertaking RCTs in CM interventions,
based on our multi-centre hospital studies in Melbourne,
Australia (Table 1). The Multiple Emergency Department
Acupuncture Trial (MEDACT) evaluated the analgesic
effect of acupuncture for patients presenting to theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of the MEDACT and GEARS clinical trials
MEDACT GEARS
Condition treated Acute pain; ankle sprain, non-specific low back pain or migraine COPD
Design RCT RCT
Funding source Government funding body (NHMRC) Government funding body (NHMRC)
Source of patients Hospital ED Community and outpatients
Location of patient visits Hospital ED Hospital outpatients
Number of sites 4 4
Number of participants 505 168
Number of groups 3 2
Intervention Acupuncture or acupuncture plus standard care (pharmacotherapy) Panax ginseng (herb)
Control Standard care (pharmacotherapy) Placebo
Treatment duration 1 treatment 6 months
Follow-up 48 hours 6 months
Outcomes 1. Pain and disability scales 1. Quality of life
2. Quality of life 2. Lung function
3. Acceptably of treatment and willingness to repeat 3. Use of relief medication
4. Adverse events 4. Exacerbations
5. Health resource utilization 5. Adverse events
Recruitment status Completed: target reached 2011 Ongoing: completion target 2013
COPD: Chronic obstructive pulmonary disease, ED: Emergency department, GEARS: Ginseng extract and respiratory symptoms clinical trial, MEDACT: Multiple
emergency department acupuncture control trial, NHMRC: National Health and Medical Research Council, RCT: Randomized controlled trial.
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sprain or migraine [13]. This study was pragmatic in de-
sign and allocated participants randomly to one of three
groups: acupuncture alone; acupuncture plus pharmaco-
therapy; and pharmacotherapy alone. Recruitment oc-
curred in four EDs and the primary outcome was pain
relief after one hour. The Ginseng Extract and Respiratory
Symptoms (GEARS) is ongoing, and is evaluating the effi-
cacy of a herbal medicine in participants with chronic ob-
structive pulmonary disease (COPD) [14]. This study is a
two-arm parallel RCT and participants are recruited
through four metropolitan hospitals. This paper will dis-
cuss the issues we encountered, including protocol design,
personnel and resources, and participant recruitment.Protocol design
RCTs should meet standards of rigorous scientific design.
RCTs need to incorporate design elements to maintain in-
ternal and external validity for generalisability. In Australian
hospitals, CM treatments are not prescribed routinely; thus,
researchers need to ensure that the trial is implemented in
accordance with hospital policies and guidelines without
compromising the quality of the research. Furthermore, in
order to be clinically relevant, the results of the trial should
be translatable to a clinical practice setting.
A major consideration in designing a hospital-based CM
RCT is the study design. Feasible protocols are required toimplement and researchers need to consider the appro-
priateness and justification for complex individualised
interventions and non-standard treatments, particularly
when using herbal medicines [15].
Another main consideration for CM studies is the jus-
tification of intervention. This is determined predomi-
nantly through historical use and is usually supported by
records with pharmacological and toxicological reports
and detailed information of the herbal product’s con-
stituents. Acupuncture studies may encounter similar
questions regarding evidence base and mechanism of ac-
tion, to justify its use for a particular health condition.
Traditional CM diagnosis and treatment are based on
interview and observation of the patient, and do not re-
quire instrumental tests, as in WM. When a WM diag-
nosis is required to assess eligibility for inclusion in a
pragmatic trial, and the CM diagnosis is used only to
guide selection of an appropriate treatment for each in-
dividual, the trial may be better suited to the hospital
setting. For example, the MEDACT study required the
WM diagnosis of an ankle sprain, migraine or low back
pain [13]. Although a CM diagnosis was not an inclusion
criterion, the acupuncturists were able to select appro-
priate acupuncture points based on CM theory.
In contrast, the GEARS study included participants
according to the WM diagnosis of COPD in addition to
the CM diagnosis of lung qi deficiency or spleen qi defi-
ciency, or both. The intervention in this study was a
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ciency, or both [14]. The WM and CM diagnoses
enabled the translation of the outcomes into clinical
practices.
The RCTs that require specialist testing and diagnostic
equipment to confirm a diagnosis may be better suited
to the hospital setting. Through negotiation with rele-
vant hospital departments, access to testing and equip-
ment may facilitate trial recruitment and reduce costs.
Diagnostic X-ray was often required in the MEDACT
study to exclude injuries caused by fracture. In the
GEARS study, lung function testing was underta-
ken using spirometry, hospital pathology laboratories
performed full blood examinations, including tests of
liver and kidney function and trial medications were
dispensed from the hospital pharmacy.
Personnel and resources
Conducting a high standard clinical trial requires a
dedicated and experienced research team. Skilled
investigators and trial coordinators are frequently
employed by hospital research departments and are es-
sential in a successful study [16]. The culture of an or-
ganisation and their openness to CM theory will aid in
the conduct of the trial and contribute to recruitment
success [17]. A hospital setting would be counterpro-
ductive if researchers in hospitals are not enthusiastic in
CM research projects.
In the MEDACT study, ED doctors confirmed eligibil-
ity of participants then qualified acupuncturists delivered
the acupuncture treatments. In the GEARS study, a
qualified CM practitioner was employed during the
screening process to ensure the participants met the
pre-specified CM diagnostic criteria. All other activities,
including randomisation, were completed by a clinical
trial coordinator employed by the hospitals.
Study sites should be accessible to trial participants
and responsive to queries if problems arise. Hospitals
often have an established research culture and can offer
a setting that improves the running of trials by providing
the facilities required to ensure ‘Good Clinical Practice’
(GCP). Other advantages include the availability of fa-
cilities (e.g., radiology and pathology equipment) and
trained specialized staff. Hospital based pharmacy de-
partments are often a convenient location for storing
and dispensing study medications, which assist in
maintaining the integrity of blinding. Availability of
these facilities was crucial to the conduct of both
MEDACT and GEARS.
Hospitals have the potential to be more expensive than
universities or clinic settings for conducting RCTs when
taking into account the costs of site-set up, ongoing fees,
personnel, per-recruitment charges and the legal costs of
clinical trial agreements. This was found to be the casefor the GEARS study. The study incurred approximately
$5,500 (Australian dollars) of additional hospital fees per
site. This included ethics, site-set up, administration fees,
ongoing fees, and additional per-recruitment charges
of up to $250. The MEDACT study also incurred si-
milar costs.Participant recruitment
Recruitment and retention of participants in clinical
trials can be challenging due to trial-specific demands,
the availability of patients, the preferences of patients
and informed consent [18]. Individuals may participate
in CM studies just as willingly as WM studies [19]; how-
ever, there is a dearth of research evaluating how the
trial site might influence study participation.
The attitudes of potential participants towards CM
clinical trials also influence recruitment [17,20]. Positive
attitudes in recruitment for CM clinical trials include:
(1) CM is considered safer and less invasive than WM;
(2) CM treatments may help to reduce dependence on
conventional medications; and (3) the willingness of
participants to try new interventions at little cost or
harm to themselves. By contrast, barriers to recruitment
include: (1) doubt about the effectiveness of treatments;
(2) lack of knowledge of how CM may work; (3)
participants are not willing to change their current
health care options and reluctant for randomisation
when CM treatments are readily available in the
community.
In the MEDACT study, patients were approached for
screening soon after triage by the ED nurse. An early ap-
proach appeared to improve the chances of participa-
tion. The steady flow of patients through the ED
combined with the motivation of these patients to obtain
pain relief enabled satisfactory recruitment within a rela-
tively short period. Little advertisement or incentive
saved costs and enabled staff to concentrate on the ED
during peak times in order to maximise recruitment.
A different recruitment strategy was used for the
GEARS study as patients with stage II COPD were more
likely to be outpatients. The recruitment strategy in-
cluded media promotion, advertising in clinic rooms,
and physician referrals. As this trial has not been
completed, we have not yet evaluated the recruitment
strategy.
Conclusion
The appropriateness of conducting a hospital-based CM
clinical trial depends on the requirements for the clinical
setting. We identified several key elements to consider
before conducting a CM RCT in a hospital, including
protocol design; personnel and resources; and partici-
pant recruitment.
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